Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Biliary Cirrhosis

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Biliary Cirrhosis:

Pubmed Logo
Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up.
Background: Fatigue was recently suggested to predict an increased risk of...
20th November, 2009
Department of Internal Medicine, Section of Gastroenterology and Liver Int. 2009 Nov 17.
DOI Direct Link
Extrahepatic conditions associated with primary biliary cirrhosis.
Background: Fatigue was recently suggested to predict an increased risk of...
18th November, 2009
Hepatogastroenterology Department, Hospital Universitario de La Princesa, Hepatology. 2009 Aug 10.
DOI Direct Link
Hepatic pseudolymphoma: a clinicopathological study of five cases and review of the literature.
Hepatic pseudolymphoma is a rare and controversial condition, the...
17th November, 2009
[1] Institute of Liver Studies, King's College Hospital, London, UK [2] Mod Pathol. 2009 Nov 13.
DOI Direct Link
CX3CL1 (fractalkine): A signpost for biliary inflammation in primary biliary cirrhosis.
Improvements in the treatment of primary biliary cirrhosis (PBC) may...
13th November, 2009
Department of Medicine and Biosystemic Science, Kyushu University Graduate Hepatology. 2009 Nov 11.
DOI Direct Link
[Primary biliary cirrhosis]
In the Netherlands there are probably several thousands of patients with...
11th November, 2009
Erasmus MC, afd. Maag-, Darm- en Leverziekten, Rotterdam, The Netherlands. Ned Tijdschr Geneeskd. 2009;153:A483.

View more research publications.

Press Releases About Biliary Cirrhosis:

BioPortfolio Logo
Ocera Therapeutics Presents Clinical Data Demonstrating AST-120 Relieves Pruritus in Patients with Liver Cirrhosis at the 60th Annual AASLD Meeting 2nd November, 2009 Ocera Therapeutics, Inc.
BOSTON, Nov. 2 /PRNewswire/ -- Ocera Therapeutics, Inc. announced today that AST-120 (spherical carbon adsorbent) was shown to reduce the severity of pruritus (itching) in patients with chronic liver
Vitamin Supplements Insufficient for Children with Biliary Atresia 27th October, 2009 American Association for the Study of Liver Diseases (AASLD)
WASHINGTON and BOSTON, Oct. 27 /PRNewswire/ -- Commercially available multivitamin preparations commonly given to infants with biliary atresia to prevent fat soluble vitamin deficiencies are
Lumenis Receives 510K Clearance for the PolyScope Disposable Flexible Endoscope 27th October, 2009 Lumenis Ltd.
-- Gastroenterology, including procedures of the Biliary system involving the hepatic and pancreatic ducts The PolyScope is an evolution in flexible scope design incorporating a truly
Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma 19th October, 2009 Jennerex, Inc.
SAN FRANCISCO, Oct. 19 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), a clinical stage biotherapeutics company developing a proprietary breakthrough product class of targeted
Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents 6th October, 2009 Boston Scientific Corporation
NATICK, Mass., Oct. 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to

BioNews Results for Biliary Cirrhosis:

RSS Logo
BioPortfolio Logo
Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
Individual.com:  Oct 28 2009 1:43AM Matching: biliary cirrhosis

Biliary Cirrhosis Patents:

USPTO Logo
US Patent No.Title
7585507 Nucleic acid molecules and polypeptides for immune modulation
7595311 Azepinoindole derivatives as pharmaceutical agents
7595318 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
7595341 Analogues of lipid mediators derived from .omega.-3 PUFAs and methods of use
7597886 Tumor necrosis factor-gamma

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Biliary Cirrhosis scientists - we have details of around 620 individuals working on Biliary Cirrhosis .


This page has been viewed 348 times
Recent Search Terms used to find this page: Promising diagnostic biomarkers for primary biliary cirrhosis identified with magnetic beads and MALDI-TOF-MS | cirrhosis and back pain | us army cirrhosis | Biliary Atresia prevalence 2008 uk | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Biliary Cirrhosis across BioPortfolio, or for Biliary Cirrhosis Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.